The neurobiological basis of narcolepsy
暂无分享,去创建一个
Thomas E. Scammell | T. Scammell | I. Koralnik | Igor J. Koralnik | Carrie E. Mahoney | Andrew Cogswell | C. E. Mahoney | A. Cogswell | Andrew C Cogswell
[1] T. Sakurai,et al. Comprehensive Behavioral Analysis of Male Ox1r−/− Mice Showed Implication of Orexin Receptor-1 in Mood, Anxiety, and Social Behavior , 2015, Front. Behav. Neurosci..
[2] E. Mignot,et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. , 2002, Archives of neurology.
[3] Denis Burdakov,et al. Glutamate and GABA as rapid effectors of hypothalamic “peptidergic” neurons , 2012, Front. Behav. Neurosci..
[4] A Stricker-Krongrad,et al. Independent feeding and metabolic actions of orexins in mice. , 1998, Biochemical and biophysical research communications.
[5] T. Scammell,et al. Dysregulation of Sleep Behavioral States in Narcolepsy , 2017, Sleep.
[6] T. Sakurai,et al. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions , 2005, Neuroscience Letters.
[7] I. Koralnik,et al. Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System , 2015, Journal of neuropathology and experimental neurology.
[8] Susumu Tanaka,et al. Anti-Tribbles Pseudokinase 2 (TRIB2)-Immunization Modulates Hypocretin/Orexin Neuronal Functions , 2017, Sleep.
[9] Sebastiaan Overeem,et al. Clinical, polysomnographic and genome‐wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study , 2013, Journal of sleep research.
[10] C. Lines,et al. Orexin receptor antagonism for treatment of insomnia , 2012, Neurology.
[11] H. Pijl,et al. Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study. , 2014, Sleep.
[12] Cecilia G Diniz Behn,et al. Abnormal sleep/wake dynamics in orexin knockout mice. , 2010, Sleep.
[13] P. Franken,et al. Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need , 2017, Proceedings of the National Academy of Sciences.
[14] E. A. Lucas,et al. Sleep cycle organization in narcoleptic and normal dogs , 1979, Physiology & Behavior.
[15] E. Mignot,et al. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. , 2009, Sleep.
[16] B. Becher,et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons , 2018, Nature.
[17] Seockhoon Chung,et al. Prevalence of narcolepsy‐cataplexy in Korean adolescents , 2008, Acta neurologica Scandinavica.
[18] T. Scammell,et al. Do enteric neurons make hypocretin? , 2008, Regulatory Peptides.
[19] T. Pollmächer,et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy , 2001 .
[20] F. Han,et al. Body weight and basal metabolic rate in childhood narcolepsy: a longitudinal study. , 2016, Sleep medicine.
[21] S. Kaur,et al. Hypocretin-2 Saporin Lesions of the Ventrolateral Periaquaductal Gray (vlPAG) Increase REM Sleep in Hypocretin Knockout Mice , 2009, PloS one.
[22] P. Luppi,et al. Brainstem mechanisms of paradoxical (REM) sleep generation , 2011, Pflügers Archiv - European Journal of Physiology.
[23] Y. Dauvilliers,et al. Narcolepsy and Other Central Hypersomnias , 2017, Continuum.
[24] A. Yamanaka,et al. Input of Orexin/Hypocretin Neurons Revealed by a Genetically Encoded Tracer in Mice , 2005, Neuron.
[25] S. Bastianini,et al. High‐amplitude theta wave bursts during REM sleep and cataplexy in hypocretin‐deficient narcoleptic mice , 2012, Journal of sleep research.
[26] Takeshi Sakurai,et al. Hypocretin/Orexin Excites Hypocretin Neurons via a Local Glutamate Neuron—A Potential Mechanism for Orchestrating the Hypothalamic Arousal System , 2002, Neuron.
[27] T. Wetter,et al. Hypothalamo–pituitary–adrenal axis, glucose metabolism and TNF‐α in narcolepsy , 2014, Journal of sleep research.
[28] Depression and Hypersomnia: A Complex Association. , 2017, Sleep medicine clinics.
[29] Sung Tae Kim,et al. Gray Matter Concentration Abnormality in Brains of Narcolepsy Patients , 2009, Korean journal of radiology.
[30] E. Mignot,et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. , 2013, Sleep.
[31] N. Risch,et al. HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group. , 1998, Tissue antigens.
[32] I. Jaussent,et al. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. , 2016, Sleep.
[33] Y. Inoue,et al. Relationship between clinical characteristics of narcolepsy and CSF orexin‐A levels , 2011, Journal of sleep research.
[34] A. Adamantidis,et al. Coreleased Orexin and Glutamate Evoke Nonredundant Spike Outputs and Computations in Histamine Neurons , 2014, Cell reports.
[35] J. Siegel,et al. Narp immunostaining of human hypocretin (orexin) neurons , 2005, Neurology.
[36] Jee Hoon Roh,et al. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. , 2013, Genes & development.
[37] T. Pollmächer,et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy , 2001, Annals of neurology.
[38] A. N. van den Pol. Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord , 1999, The Journal of Neuroscience.
[39] G. Aston-Jones,et al. Orexin/hypocretin is necessary for context-driven cocaine-seeking , 2010, Neuropharmacology.
[40] Sebastiaan Overeem,et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy , 2010, Nature Genetics.
[41] R. Huerta,et al. Mechanism for Hypocretin-mediated sleep-to-wake transitions , 2012, Proceedings of the National Academy of Sciences.
[42] Jun Lu,et al. Critical Role of Dorsomedial Hypothalamic Nucleus in a Wide Range of Behavioral Circadian Rhythms , 2003, The Journal of Neuroscience.
[43] G. Plazzi,et al. Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. , 2016, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[44] W. Dement,et al. Evidence for excessive sleepiness in canine narcoleptics. , 1986, Electroencephalography and clinical neurophysiology.
[45] E. Arrigoni,et al. Dynorphin inhibits basal forebrain cholinergic neurons by pre‐ and postsynaptic mechanisms , 2016, The Journal of physiology.
[46] E. Mignot,et al. Genome Wide Analysis of Narcolepsy in China Implicates Novel Immune Loci and Reveals Changes in Association Prior to Versus After the 2009 H1N1 Influenza Pandemic , 2013, PLoS genetics.
[47] G. Aston-Jones,et al. A Septal-Hypothalamic Pathway Drives Orexin Neurons, Which Is Necessary for Conditioned Cocaine Preference , 2012, The Journal of Neuroscience.
[48] Jon T. Willie,et al. Orexin (Hypocretin) Neurons Contain Dynorphin , 2001, The Journal of Neuroscience.
[49] Olivier Clément,et al. Localization of the Brainstem GABAergic Neurons Controlling Paradoxical (REM) Sleep , 2009, PloS one.
[50] R Broughton,et al. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. , 1986, Sleep.
[51] J. Antel,et al. Major histocompatibility complex molecules on glial cells , 1992, Seminars in Neuroscience.
[52] Y. Dauvilliers,et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice , 2016, Proceedings of the National Academy of Sciences.
[53] C. Nelson,et al. Neurochemical Heterogeneity Among Lateral Hypothalamic Hypocretin/Orexin and Melanin-Concentrating Hormone Neurons Identified Through Single-Cell Gene Expression Analysis , 2017, eNeuro.
[54] E. Mignot,et al. The autoimmune basis of narcolepsy , 2013, Current Opinion in Neurobiology.
[55] K. Vogt,et al. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models , 2017, Proceedings of the National Academy of Sciences.
[56] J. Renger,et al. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors , 2016, Nature Structural &Molecular Biology.
[57] T. Scammell,et al. Running promotes wakefulness and increases cataplexy in orexin knockout mice. , 2007, Sleep.
[58] C. Saper,et al. Hypothalamic regulation of sleep and circadian rhythms , 2005, Nature.
[59] Jon T. Willie,et al. Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal , 2003, The Journal of Neuroscience.
[60] Z. Kutalik,et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. , 2014, Sleep.
[61] M. Edwards,et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy , 2011, Brain : a journal of neurology.
[62] Y. Hishikawa,et al. The Pathophysiologic Basis of Secondary Narcolepsy and Hypersomnia , 2011, Current neurology and neuroscience reports.
[63] P. Kenny,et al. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area , 2014, Proceedings of the National Academy of Sciences.
[64] J. Siegel,et al. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. , 2009, Sleep.
[65] A. Yamanaka,et al. Orexin Directly Excites Orexin Neurons through Orexin 2 Receptor , 2010, The Journal of Neuroscience.
[66] M. Silber,et al. Comorbidities in a community sample of narcolepsy. , 2017, Sleep medicine.
[67] L. Ferrari,et al. Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons , 2018, The Journal of Neuroscience.
[68] Sebastiaan Overeem,et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.
[69] C. Burgess,et al. Amygdala Lesions Reduce Cataplexy in Orexin Knock-Out Mice , 2013, The Journal of Neuroscience.
[70] David E. Moorman,et al. Role of lateral hypothalamic orexin neurons in reward processing and addiction , 2009, Neuropharmacology.
[71] T. Sakurai,et al. Histamine‐1 receptor is not required as a downstream effector of orexin‐2 receptor in maintenance of basal sleep/wake states , 2010, Acta physiologica.
[72] Takeshi Sakurai,et al. Behavioral State Instability in Orexin Knock-Out Mice , 2004, The Journal of Neuroscience.
[73] B. Roth,et al. Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice , 2011, Neuroscience Research.
[74] J. Chapman,et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. , 2013, Journal of autoimmunity.
[75] S. Nevsimalova,et al. Reduced hypothalamic gray matter in narcolepsy with cataplexy. , 2006, Neuro endocrinology letters.
[76] Poul Jennum,et al. Absence of autoreactive CD4+ T-cells targeting HLA-DQA1*01:02/DQB1*06:02 restricted hypocretin/orexin epitopes in narcolepsy type 1 when detected by EliSpot , 2017, Journal of Neuroimmunology.
[77] C. Saper,et al. Fos Expression in Orexin Neurons Varies with Behavioral State , 2001, The Journal of Neuroscience.
[78] C. Saper,et al. A putative flip–flop switch for control of REM sleep , 2006, Nature.
[79] Abnormal , 2020, Definitions.
[80] W. Dement,et al. Circadian rhythms in narcolepsy: studies on a 90 minute day. , 1994, Electroencephalography and clinical neurophysiology.
[81] Alessandro Silvani,et al. Effects of Ambient Temperature on Sleep and Cardiovascular Regulation in Mice: The Role of Hypocretin/Orexin Neurons , 2012, PloS one.
[82] E. Mignot,et al. Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases , 2017, PloS one.
[83] C. Saper,et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy , 2005, Neurology.
[84] C. Berridge,et al. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration , 2003, Neuroscience.
[85] JaneR . Taylor,et al. Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization , 2010, Brain Research.
[86] O. Hassani,et al. Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle , 2005, The Journal of Neuroscience.
[87] S. Gammeltoft,et al. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. , 2010, Brain : a journal of neurology.
[88] G. Lammers,et al. Immunohistochemical screening for antibodies in recent onset type 1 narcolepsy and after H1N1 vaccination , 2015, Journal of Neuroimmunology.
[89] Zhe Zhang,et al. A Hypothalamic Switch for REM and Non-REM Sleep , 2018, Neuron.
[90] T. So,et al. The significance of OX40 and OX40L to T‐cell biology and immune disease , 2009, Immunological reviews.
[91] Arne Svejgaard,et al. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[92] T. Young,et al. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency. , 2013, JAMA neurology.
[93] M. Mühlethaler,et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. , 2010, The Journal of clinical investigation.
[94] M. Yanagisawa,et al. Reduced Brown Adipose Tissue Thermogenesis during Environmental Interactions in Transgenic Rats with Ataxin-3-mediated Ablation of Hypothalamic Orexin Neurons Genotyping and Immunohistochemical Verification of Phenotype Immunohistochemical Analysis of Orexin-containing Neurons and Their Axonal Proce , 2022 .
[95] Jerome M. Siegel,et al. Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons , 2005, Neuron.
[96] Sleep onset rapid‐eye‐movement episodes in narcolepsy: REM sleep pressure or nonREM‐REM sleep dysregulation? , 1992, Journal of sleep research.
[97] C. Cunningham,et al. Involvement of the orexin/hypocretin system in ethanol conditioned place preference , 2011, Psychopharmacology.
[98] Liang-Jen Wang,et al. Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan. , 2017, Sleep medicine.
[99] F E Bloom,et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[100] R. Maldonado,et al. Hypocretin/Orexin Signaling in the Hypothalamic Paraventricular Nucleus is Essential for the Expression of Nicotine Withdrawal , 2012, Biological Psychiatry.
[101] A. Lutterotti,et al. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1 , 2016, Sleep.
[102] Michael Aldrich,et al. Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.
[103] C. Gieger,et al. Narcolepsy is strongly associated with the TCR alpha locus , 2009, Nature Genetics.
[104] J. Ciriello,et al. Cardiac effects of hypocretin-1 in nucleus ambiguus. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[105] K. Deisseroth,et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons , 2007, Nature.
[106] T. Hökfelt,et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns , 2014, Proceedings of the National Academy of Sciences.
[107] T. Scammell,et al. Orexin neurons are necessary for the circadian control of REM sleep. , 2009, Sleep.
[108] Antoine Adamantidis,et al. Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks , 2016, Nature Communications.
[109] J. Peever,et al. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy , 2017, The Journal of Neuroscience.
[110] Edilio Borroni,et al. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice , 2011, Proceedings of the National Academy of Sciences.
[111] S. Miller,et al. The role of antigen presenting cells in multiple sclerosis. , 2011, Biochimica et biophysica acta.
[112] Shahar Alon,et al. Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a , 2015, eLife.
[113] S. Shioda,et al. Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine , 2006, The Journal of Neuroscience.
[114] J. Siegel,et al. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy , 2013, Annals of neurology.
[115] E. Mignot,et al. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy , 2007, The Journal of physiology.
[116] E. Mignot,et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy , 2018, Proceedings of the National Academy of Sciences.
[117] W. Dement,et al. Sleep fragmentation in canine narcolepsy. , 1986, Sleep.
[118] R. Szymusiak,et al. Efferent projections from the median preoptic nucleus to sleep- and arousal-regulatory nuclei in the rat brain , 2007, Neuroscience.
[119] Dennis McGinty,et al. The Median Preoptic Nucleus Reciprocally Modulates Activity of Arousal-Related and Sleep-Related Neurons in the Perifornical Lateral Hypothalamus , 2007, The Journal of Neuroscience.
[120] Á. Pascual-Leone,et al. Reward-seeking behavior in human narcolepsy. , 2011, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[121] Differential Roles of Orexin Receptor-1 and -2 in the Regulation of Non-REM and REM Sleep , 2011, The Journal of Neuroscience.
[122] B. Lowell,et al. GABAergic Neurons of the Central Amygdala Promote Cataplexy , 2017, The Journal of Neuroscience.
[123] P. Worley,et al. Selective expression of Narp, a secreted neuronal pentraxin, in orexin neurons , 2002, Journal of neurochemistry.
[124] C. Lines,et al. Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts , 2018, Sleep.
[125] T. Pollmächer,et al. Increased body-mass index in patients with narcolepsy , 2000, The Lancet.
[126] C. M. Linton. Narcolepsy without Cataplexy , 2013 .
[127] E. Mignot,et al. Autoimmunity to hypocretin and molecular mimicry to flu antigens in Type 1 narcolepsy , 2018, bioRxiv.
[128] T. Koepsell,et al. Prevalence of narcolepsy in King County, Washington, USA. , 2009, Sleep medicine.
[129] N Risch,et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. , 2001, American journal of human genetics.
[130] E. Mignot,et al. Primary progressive narcolepsy type 1: The other side of the coin , 2014, Neurology.
[131] E. Matsushima,et al. Comparison of clinical characteristics among narcolepsy with and without cataplexy and idiopathic hypersomnia without long sleep time, focusing on HLA-DRB1( *)1501/DQB1( *)0602 finding. , 2009, Sleep medicine.
[132] T. Sakurai,et al. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. , 2014, The Journal of clinical investigation.
[133] M. Partinen,et al. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. , 2017, Sleep medicine reviews.
[134] A. Régnault,et al. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells , 2017, PloS one.
[135] A. Yamanaka,et al. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. , 2016, Sleep.
[136] E. Mignot,et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. , 2012, Sleep.
[137] T. Scammell,et al. Afferents to the orexin neurons of the rat brain , 2006, The Journal of comparative neurology.
[138] P. Luppi,et al. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep , 2018, Sleep.
[139] J. Ciriello,et al. Cardioacceleratory responses to hypocretin-1 injections into rostral ventromedial medulla , 2003, Brain Research.
[140] E. Mignot,et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china , 2011, Annals of neurology.
[141] M. Partinen,et al. Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk , 2014, PloS one.
[142] J. Paton,et al. Antagonism of orexin receptors significantly lowers blood pressure in spontaneously hypertensive rats , 2013, The Journal of physiology.
[143] P. Jennum,et al. Sleep-wake stability in narcolepsy patients with normal, low and unmeasurable hypocretin levels. , 2017, Sleep medicine.
[144] N. Guex,et al. A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. , 2011, American journal of human genetics.
[145] M. Littner,et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. , 2005, Sleep.
[146] Mayumi Takasaki,et al. Sympathetic and cardiovascular actions of orexins in conscious rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[147] Z. Kutalik,et al. Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity. , 2016, Sleep.
[148] R. Rappuoli,et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 , 2015, Science Translational Medicine.
[149] Susumu Tanaka,et al. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. , 2006, Sleep.
[150] R. DiLeone,et al. Orexin Mediates the Expression of Precipitated Morphine Withdrawal and Concurrent Activation of the Nucleus Accumbens Shell , 2008, Biological Psychiatry.
[151] E. Mignot,et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. , 2009, Sleep.
[152] M. Mitler,et al. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. , 1977, Electroencephalography and clinical neurophysiology.
[153] A. Kelley,et al. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action , 2001, Neuroscience.
[154] Sebastiaan Overeem,et al. Hypocretin (orexin) deficiency in human narcolepsy , 2000, The Lancet.
[155] E. Mignot,et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. , 2002, Sleep.
[156] H. Inoko,et al. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. , 1986, Sleep.
[157] C. Heidbreder,et al. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward , 2011, Behavioural pharmacology.
[158] Damien Gervasoni,et al. Paradoxical (REM) sleep genesis: The switch from an aminergic–cholinergic to a GABAergic–glutamatergic hypothesis , 2006, Journal of Physiology-Paris.
[159] N. Dahmen,et al. Basal metabolic rate in narcoleptic patients. , 2009, Sleep.
[160] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[161] D. Auer,et al. Reduced cortical gray matter in narcolepsy: Preliminary findings with voxel-based morphometry , 2002, Neurology.
[162] P. Carrive,et al. Both Ox1r and Ox2r orexin receptors contribute to the cardiovascular and locomotor components of the novelty stress response in the rat , 2015, Neuropharmacology.
[163] M. Tafti,et al. Comment on “Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2” , 2015, Science Translational Medicine.
[164] V. Pankratz,et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. , 2002, Sleep.
[165] C. Gieger,et al. ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy , 2013, PLoS genetics.
[166] Emmanuel Mignot,et al. The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.
[167] H. Pijl,et al. Increased heart rate variability but normal resting metabolic rate in hypocretin/orexin-deficient human narcolepsy. , 2008, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[168] C. Guilleminault,et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. , 1997, Sleep.
[169] K. Deisseroth,et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons , 2010, Nature Neuroscience.
[170] P. Bonaventure,et al. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement , 2011, Psychopharmacology.
[171] C. Leonard,et al. Cholinergic Modulation of Narcoleptic Attacks in Double Orexin Receptor Knockout Mice , 2011, PloS one.
[172] S. Hong. Neuroimaging of Narcolepsy and Kleine-Levin Syndrome. , 2017, Sleep medicine clinics.
[173] C. Malanga,et al. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss–Webster mice , 2012, Brain Research.
[174] A. Desautels,et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. , 2015, American journal of human genetics.
[175] I. Arnulf,et al. Eating disorder and metabolism in narcoleptic patients. , 2007, Sleep.
[176] S. Carr,et al. Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.
[177] G. Aston-Jones,et al. Arousal and reward: a dichotomy in orexin function , 2006, Trends in Neurosciences.
[178] I. Jaussent,et al. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy , 2017, Sleep.
[179] M. Partinen,et al. Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland , 2012, PloS one.
[180] Yuqing Shen,et al. Developmental expression and localization of MHC class I molecules in the human central nervous system , 2015, Experimental Brain Research.
[181] Kenji F. Tanaka,et al. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice , 2013, Behavioural Brain Research.
[182] Daniela Schlatzer,et al. Proteomic profiling of the hypothalamus in two mouse models of narcolepsy , 2017, Proteomics.
[183] E. Mignot,et al. Hypocretin Levels in Sporadic and Familial Cases of Canine Narcolepsy , 2001, Neurobiology of Disease.
[184] Y. Dauvilliers,et al. Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy , 2010, PloS one.
[185] O. Masseck,et al. Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity , 2017, Proceedings of the National Academy of Sciences.
[186] T. Sakurai,et al. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[187] A. Pol. Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord , 1999 .
[188] J. Buckner. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases , 2010, Nature Reviews Immunology.
[189] E. Mignot,et al. Increase of histaminergic tuberomammillary neurons in narcolepsy , 2013, Annals of neurology.
[190] Jon T. Willie,et al. Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity , 2001, Neuron.
[191] Y. Dauvilliers,et al. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. , 2013, Sleep.
[192] S. Borgland,et al. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons. , 2017, Cell reports.
[193] C. Howe,et al. Retrograde interferon‐gamma signaling induces major histocompatibility class I expression in human‐induced pluripotent stem cell‐derived neurons , 2017, Annals of clinical and translational neurology.
[194] D. Linden,et al. Narp regulates homeostatic scaling of excitatory synapses on Parvalbumin interneurons , 2010, Nature Neuroscience.
[195] C. Saper,et al. Role of the Medial Prefrontal Cortex in Cataplexy , 2013, The Journal of Neuroscience.
[196] E. Katz,et al. Usefulness of a Nocturnal SOREMP for Diagnosing Narcolepsy with Cataplexy in a Pediatric Population. , 2015, Sleep.
[197] R. Cools,et al. Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. , 2016, Sleep.
[198] M. Edwards,et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy , 2013, Brain : a journal of neurology.
[199] H. Pijl,et al. Spontaneous food choice in narcolepsy. , 1996, Sleep.
[200] D. Burdakov,et al. Orexin-driven GAD65 network of the lateral hypothalamus sets physical activity in mice , 2017, Proceedings of the National Academy of Sciences.
[201] A. N. van den Pol,et al. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.
[202] P. Franco,et al. Depressive feelings in children with narcolepsy. , 2014, Sleep medicine.
[203] Ming-Fung Wu,et al. Cataplexy-Active Neurons in the Hypothalamus Implications for the Role of Histamine in Sleep and Waking Behavior , 2004, Neuron.
[204] Jon T. Willie,et al. Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice Molecular Genetic Dissection of Non-REM and REM Sleep Regulatory Processes , 2003, Neuron.
[205] R. Maki,et al. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. , 2001, Genome research.
[206] R. Maldonado,et al. Hypocretins Regulate the Anxiogenic-Like Effects of Nicotine and Induce Reinstatement of Nicotine-Seeking Behavior , 2010, The Journal of Neuroscience.
[207] A. Yamanaka,et al. Conditional Ablation of Orexin/Hypocretin Neurons: A New Mouse Model for the Study of Narcolepsy and Orexin System Function , 2014, The Journal of Neuroscience.
[208] K. Hirata,et al. New susceptibility variants to narcolepsy identified in HLA class II region. , 2015, Human molecular genetics.